Literature DB >> 9162610

Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM families.

M Armstrong1, F Haldane, P J Avery, J Mitcheson, M W Stewart, D M Turnbull, M Walker.   

Abstract

Insulin receptor substrate-1 (IRS-1) occupies a key position in the insulin-signalling pathway. Two mutations of the IRS-1 gene (Gly(972)Arg and Ala(513)Pro) have been described, although their roles in the development of insulin resistance and non-insulin-dependent diabetes mellitus (NIDDM) remain controversial. Insulin resistance has been described in non-diabetic relatives of NIDDM families, suggesting that it may be due to an inherited defect of insulin action. We therefore examined the relationships between the two mutations and insulin sensitivity in 93 non-diabetic first degree relatives from North European families with 2 or more living NIDDM subjects. Anthropometric measurements, an oral glucose tolerance test, and an insulin tolerance test to assess insulin sensitivity (K(ITT)) were performed. Basal insulin sensitivity was assessed by homeostasis model assessment (HOMA). Comparisons were made between the following relative subgroups: with (n = 9) and without (n = 84) the 972 mutation; with (n = 5) and without (n = 88) the 513 mutation; and with either one or both mutations (n = 13) or without either (n = 80). General linear model analysis was used to compare K(ITT) and HOMA between the subgroups with the anthropometric variables known to influence insulin sensitivity as covariates. There were no significant differences between the subgroups for K(ITT) and HOMA. In conclusion, the 513 and 972 mutations, alone and in combination, are not associated with decreased insulin sensitivity in non-diabetic relatives of NIDDM families.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9162610     DOI: 10.1002/(SICI)1096-9136(199604)13:4<341::AID-DIA80>3.0.CO;2-F

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors.

Authors:  Jing Fan; Roberta McKean-Cowdin; Leslie Bernstein; Frank Z Stanczyk; Arthur Xuejun Li; Rachel Ballard-Barbash; Anne McTiernan; Richard Baumgartner; Frank Gilliland
Journal:  Breast Cancer Res Treat       Date:  2006-06-05       Impact factor: 4.872

2.  Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies.

Authors:  A Jellema; M P A Zeegers; E J M Feskens; P C Dagnelie; R P Mensink
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

3.  Association between IRS-1 Gly972Arg polymorphism and colorectal cancer risk.

Authors:  Peng Li; Lingjun Wang; Lihua Liu; Hong Jiang; Chong Ma; Tao Hao
Journal:  Tumour Biol       Date:  2014-04-03

4.  ASSOCIATION OF IRS1 GLY971ARG GENE POLYMORPHISM WITH INSULIN RESISTANCE IN IRANIAN NEWLY DIAGNOSED DIABETIC ADULTS.

Authors:  H Shakeri; A Khoshi; M Kaffash Bajestani; A Farahi; M S Javadzadeh; Z Hosseini; R Mohammadi
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

5.  Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism.

Authors:  Ta-Chin Lin; Jui-Mei Yen; Kum-Bing Gong; Tsung-Cheng Kuo; Dong-Chi Ku; Shu-Fen Liang; Ming-Jiuan Wu
Journal:  BMC Med Genet       Date:  2006-04-07       Impact factor: 2.103

6.  IRS1 gene polymorphisms Gly972Arg and Ala513Pro are not associated with insulin resistance and type 2 diabetes risk in non-obese Turkish population.

Authors:  Hilal Arikoglu; Melda Aksoy Hepdogru; Dudu Erkoc Kaya; Aycan Asik; Suleyman Hilmi Ipekci; Funda Iscioglu
Journal:  Meta Gene       Date:  2014-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.